Chapter 1 of 11: Before the interview
Integrates molecular testing data with morphology for diagnosis, therapy guidance, and prognosis in hematopathology.
Practicing hematopathology in the molecular era requires integrating genetic and molecular data with morphology to achieve precise diagnoses, guide therapy, and determine prognosis. The talk reviews multiple diagnostic modalities including cytogenetics, karyotyping, FISH, microarrays, and next-generation sequencing, detailing their respective analytical sensitivities, start points, and limitations. Case examples illustrate the application of clonality testing, next-generation sequencing assays like clonoSEQ for minimal residual disease, and chromosomal translocations in lymphoid and myeloid malignancies. The presentation concludes by examining the molecular classification of aggressive lymphomas, acute myeloid leukemias, and myeloproliferative neoplasms, alongside challenges in interpretation and technical pitfalls.
Practicing hematopathology in the molecular era requires integrating genetic and molecular data with morphology to achieve precise diagnoses, guide therapy, and determine prognosis. The talk reviews multiple diagnostic modalities including cytogenetics, karyotyping, FISH, microarrays, and next-generation sequencing, detailing their respective analytical sensitivities, start points, and limitations. Case examples illustrate the application of clonality testing, next-generation sequencing assays like clonoSEQ for minimal residual disease, and chromosomal translocations in lymphoid and myeloid malignancies. The presentation concludes by examining the molecular classification of aggressive lymphomas, acute myeloid leukemias, and myeloproliferative neoplasms, alongside challenges in interpretation and technical pitfalls.
Blood Cancer Journal (2013) 3, e127; doi:10.1038/bcj.2013.26
Du et al Blood 2001
Du et al Blood 2002
Attygalle et al Blood 2004
MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia
BRAF Mutations in Hairy-Cell Leukemia

This lecture
Choose a node to see how it connects to this lecture. What comes before is on the leftat the top. The ring is what it teaches. People and places are above. Other lectures and books are below.
Press a chosen node again to open it.
Your comment is kept while you sign up.Sign in
Erdheim-Chester disease treatment with vemurafenib
Molecular classification of Diffuse large B cell lymphoma
WHO 5th edition classification of myeloid neoplasms
ICC classification 2022
The Cancer Genome Atlas Research Network paper on significant mutated genes in AML
NCCN Guidelines Version 2.2025 Acute Myeloid Leukemia
NCCN Guidelines Version 3.2025 Chronic Myeloid Leukemia
WHO classification of tumours